Atorvastatin reduces microalbuminuria in patients with familial hypercholesterolemia and normal glucose tolerance

Medical Science Monitor

Volumn 9, Issue 7, 2003, Pages

  Sinzinger, Helmut ^a   Kritz, Harald ^a   Furberg, Curt D ^b  

^a ATHOS   (Austria)

^b WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

Atorvastatin; Blood pressure; Familial hypercholesterolemia; Microalbuminuria

Indexed keywords

ATORVASTATIN; CREATININE; LOW DENSITY LIPOPROTEIN CHOLESTEROL; UREA;

ADULT; ARTICLE; BLOOD PRESSURE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; CREATININE CLEARANCE; DRUG DOSE REGIMEN; DRUG EFFECT; FAMILIAL HYPERCHOLESTEROLEMIA; FEMALE; GLUCOSE TOLERANCE; HUMAN; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; MICROALBUMINURIA; TREATMENT OUTCOME; UREA BLOOD LEVEL;

ADULT; ALBUMINURIA; ANTICHOLESTEREMIC AGENTS; BLOOD GLUCOSE; CASE-CONTROL STUDIES; CHOLESTEROL, LDL; CREATININE; FEMALE; HEPTANOIC ACIDS; HOMEOSTASIS; HUMANS; HYPERLIPOPROTEINEMIA TYPE II; MALE; MIDDLE AGED; PYRROLES;

EID: 0041468953     PISSN: 12341010     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Steinmetz A, Schafer JR: Secondary disorders of lipid metabolism, metabolic syndrome and familial combined hyperlipidemia. Wr Med Wschr, 1994; 144: 299-307
2. Ross R: The pathogenesis of atherosclerosis - an update. N Engl J Med, 1986; 314: 488-500
3. Basdevant A, Cassuto D, Gibault T et al: Microalbuminuria and body fat distribution in obese subjects. Int J Obes Relat Metab Disord, 1994; 18: 806-11
4. Haffner SM, Stern MP, Gruber MKK et al: Microalbuminuria: Potential marker for increased cardiovascular risk factor in non-diabetic subjects? Arteriosclerosis, 1990; 5: 727-31
5. Jensen JS, Borch Johnsen K, Jensen G, Feldt Rasmussen B: Atherosclerotic risk factors are increased in clinically healthy subjects with microalbuminuria. Atherosclerosis, 1995; 112: 245-52
6. Winocour PH, Harland J, Millar JP et al: Microalbuminuria and associated risk factors in the community. Atherosclerosis, 1992; 93: 71-81
7. Mantari M, Tiula E, Alikoski T, Manninen V: Effects of hypertension and dyslipidemia on the decline in renal function. Hypertension, 1995; 26: 670-5
8. Oda H, Keane F: Lipids in progression of renal disease. Kidney Internat, 1997; 52: 36-8
9. Aakhus S, Dabl K, Wideroe TE. Hyperlipidemia in renal transplant patients. J Intern Med, 1996; 239: 407-15
10. Yanagisawa T, Otsubo O, Nozaki H et al: Massive proteinuria after renal transplantation treated with LDL-apheresis. Transplant Proc, 1996; 28: 1482-3
11. Yudkin JS, Forrest RD, Jackson CA: Microalbuminuria as a predictor of vascular disease in non-diabetic subjects. Islington Diabetes Survey. Lancet, 1988; 2: 530-3
12. Metcalf PA, Baker JR, Scragg RKR et al: Albuminuria in people at least 40 years old: effect of alcohol consumption, regular exercise and cigarette smoking. Clin Chem, 1993; 39: 1793-7
13. Klarlund M, Priemé H, Loft S, Enghusen Poulsen H: Smoking cessation does not change urinary albumin excretion in normal subjects. Scand J Clin Lab Invest, 1997; 57: 513-20
14. Sinzinger H, Kritz H: LDL-apheresis improves microalbuminuria in patients with severe heterozygous hypercholesterolemia. Atherosclerosis, 1999; 143: 223-4
15. Sinzinger H, Kritz H, Schwarz B: Austrian Cholesterol Consensus Conference. Richtlinien des Cholesterin-Konsensus 1995. Wr klin Wschr, 1995; 107: 537-9
16. Moro E, Zambon C, Pianetti S et al: Electronegative low density lipoprotein subform (LDL-) is increased in type 2 (non-insulin-dependent) microalbuminuric diabetic patients and is closely associated with LDL susceptibility to oxidation. Acta Diabetol, 1998; 35: 161-4
17. Hommel E, Mathiesen ER, Edsberg B et al: Acute reduction of arterial blood pressure reduces urinary albumin excretion in type I (insulin-dependent) diabetic patients with incipient nephropathy. Diabetologica, 1986; 29: 211-5
18. Chan PCK, Robinson JD, Yeung WC et al: Lovastatin in glomerulonephritis patients with hyperlipidaemia and heavy proteinuria. Nephrol Dial Transplant, 1992; 7: 93-9
19. Fuiano G, Esposito C, Sepe V et al: Effects of hypercholesterolemia on renal hemodynamics: Study in patients with nephrotic syndrome. Nephron, 1996; 73: 430-5
20. Nielsen S, Schmitz O, Moller N et al: Renal function and insulin sensitivity during simvastatin treatment in type 2 (non-insulin-dependent) diabetic patients with microalbuminuria. Diabetologia, 1993; 36: 1079-86
21. Zhang A, Vertommen S, Van Gaal L, De Lecuw I: Effects of pravastatin on lipid levels, in-vitro oxidizability of non-HDL lipoproteins and microalbuminuria in 1DDM patients. Diab Res Clin Pract, 1995; 29: 189-94
22. Hommel E, Andersen P, Gall MA et al: Plasma lipoproteins and renal function during simvastatin treatment in diabetic nephropathy. Diabetologia, 1992; 35: 447-51
23. Nakano H, Yamada K, Nishimura M et al: Effect of hypercholesterolemia on vascular endothelial function and albumin excretion rate in patients with diabetes mellitus. Nippon Jinzo Gakkai Shi, 1996; 38: 507-12
24. Kasiske BL, Velosa JA, Halstenson CE et al: Original investigations. The effects of lovastatin in hyperlipidemic patients with the nephrotic syndrome. Am J Kidney Dis, 1990; 15: 8-15
25. Wanner C, Greiber S, Krämer-Guth A et al: Lipids and progression of renal disease: Role of modified low-density lipoprotein and lipoprotein(a). Kidney International, 1997; 63: 102-6